BOSTON — HIV can be suppressed when the long-acting combination of cabotegravir plus rilpivirine (Cabenuva, ViiV Healthcare) is administered every 8 weeks, according to data from the ATLAS-2M study, ...

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug Administration to be used to prevent HIV. Gilead Sciences, maker of the drug, ...

Add Yahoo as a preferred source to see more of our stories on Google. AUSTIN (KXAN) — Advocates for HIV prevention are calling a newly approved injectable medication a major step in eliminating the ...

HIV is a virus that attacks the body’s immune system. There is currently no effective cure, but HIV treatment can help people ...

Long-acting injectable antiretroviral therapy (ART) can be administered at home to persons living with HIV as safely and effectively by a health care professional as in the clinic, with equally high ...

Twice-yearly shots used to treat AIDS were 100% effective in preventing new infections in women, according to a new study. There were no infections among the young women and girls who received the ...

Spain becomes first in the EU to fund HIV prevention injection, with rollout starting in 2026 through public healthcare.

When it comes to HIV medication, many patients think they'd prefer an occasional injection over a daily pill, but uptake ...

Please provide your email address to receive an email when new articles are posted on . HHS recommends ART for all children with HIV, regardless of clinical stage or CD4+ count, and rapid initiation ...

HIV prevention has leaped forward with the development of a yearly injection that may offer long-term protection against the virus. A recent clinical trial has demonstrated promising results, ...

More than four decades into the HIV epidemic, progress has transformed treatment and prevention, yet the need remains urgent.

Lenacapavir, a new HIV prevention drug, has proven to dramatically reduce the risk of infection according to data reported from the drugmaker Gilead Sciences, who found two annual injections of the ...